Clinical Trials Browser

IPI-926 × Tumor-Agnostic × Clear all

NCT00761696 2012-06-21

A Phase 1 Study of IPI-926 in Patients With Advanced and/or Metastatic Solid Tumor Malignancies

Phase 1 Completed

Neoplasms